Overview
Colorectal cancer screening is the systematic testing of asymptomatic individuals to detect colorectal cancer and its precursor lesions at an early, more treatable stage, with the dual goals of reducing incidence through removal of premalignant polyps and lowering mortality through earlier diagnosis. Established modalities include stool-based tests such as the fecal immunochemical test, endoscopic examinations including colonoscopy and sigmoidoscopy, and structured population programs that determine eligibility, intervals, and follow-up. Research in this area examines both the performance of screening tests and the design and implementation of screening programs. Studies of company-based and population-based screening evaluate compliance and yield using fecal immunochemical testing across large cohorts, and consider how programs can be developed in varied health-system settings. Investigations of proximal colonic anatomy and serrated lesions address the biological basis of interval cancers that escape detection, while work on emerging molecular approaches, including microRNA quantification in stool, points toward complementary screening tools. Behavioral and psychological dimensions, such as the experience and perceived risks of colonoscopy, are also studied alongside chemoprevention and the pathways of colorectal carcinogenesis. Together this literature treats screening as a multi-component strategy combining test accuracy, programmatic delivery, and an understanding of tumor biology to interrupt colorectal cancer before it advances.
Research published in this journal
11 peer-reviewed articles, ranked by relevance. Each links to its DOI.
A Roadmap to Developing a Population-Based Colorectal Cancer Screening Program in Oman
Taller Haustral Folds in the Proximal Colon: A Potential Factor Contributing to Interval Colorectal Cancer
Psychological “Risks” of Colonoscopy are Greater Amongst Fecal Immunohistochemical Test Positive Individuals than those with Inflammatory Bowel Disease
Preoperative and Postoperative N-terminal Pro B-type Natriuretic Peptide Levels Predict Cardiac Morbidity and Mortality in Patients Undergoing Colorectal Cancer Resection
Serrated Lesions of Colorectum: A New Pathway in Colorectal Carcinogenesis
Current Status of Nonsteroidal Anti-Inflammatory Drugs in Colorectal Cancer Prevention
Overexpression of Prostate Apoptosis Response Protein-4 In Colon Cancer Cells Can Inhibit Metastasis by Upregulating E-cadherin Expression
Oxidative Telomere Attrition, Nutritional Antioxidants and Biological Aging
Quantification of Micrornas by Absolute Dpcr for the Diagnostic Screening of Colon Cancer
Restoration of Bowel Continuity After Emergency Hartmann’s Procedure
How this research is being cited
The 11 articles above have been cited 36 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Diagnostic and Therapeutic Potential of Selected microRNAs in Colorectal Cancer: A Literature Review2025 · Cancers
-
Zepeng Wang et al. · 2025 · Multibody system dynamics
-
2025 · Multibody System Dynamics
-
2025 · Journal of Onco-Anaesthesiology and Perioperative Medicine
-
Diagnostic and Therapeutic Potential of Selected microRNAs in Colorectal Cancer: A Literature Review2025 · Cancers
-
2024 · Diagnostics
-
Yao Yan et al. · 2024 · European Journal of Mechanics - A/Solids
-
2024 · European Journal of Mechanics - A/Solids
A sample of recent works citing this journal's research on Colorectal Cancer Screening, linking to each citing work.